Ars Investment Partners, LLC Novartis Ag Transaction History

Ars Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$85.24 - $94.15 $204,576 - $225,960	-2,400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $194,232 - $218,640	2,400 New	2,400 $210,000
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $169,608 - $237,624	-2,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $213,850 - $235,650	-2,500 Reduced 51.02%	2,400 $209,000
Q2 2019 Aug 12, 2019	BUY	$75.4 - $92.8 $188,500 - $232,000	2,500 Added 104.17%	4,900 $447,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $176,784 - $196,848	-2,400 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $160,656 - $185,832	2,400 New	2,400 $207,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Investment Partners, LLC with notifications on news.